Carson Wealth (CWM LLC)
BCAX

Carson Wealth (CWM LLC)’s Bicara Therapeutics BCAX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6K Sell
1,138
-20
-2% -$344 ﹤0.01% 4331
2025
Q4 		$19K Sell
1,158
-197
-15% -$3.37K ﹤0.01% 4215
2025
Q3 		$21K Buy
1,355
+1,184
+692% +$13.3K ﹤0.01% 4106
2025
Q2 		$2K Sell
171
-2,027
-92% -$24.2K ﹤0.01% 4953
2025
Q1 		$29K Buy
+2,198
New +$29.2K ﹤0.01% 3430

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Carson Wealth (CWM LLC)'s BCAX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Bicara Therapeutics (BCAX) stake by 1.7% in Q1 2026, selling an estimated $344 and leaving 1,138 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4331.

Carson Wealth (CWM LLC) first reported a position in BCAX in Q1 2025 and has held it in 5 quarters since. The position peaked at $29K in Q1 2025. 146 funds tracked by Wall St. Rank hold BCAX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,138 shares of Bicara Therapeutics worth $22.6K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 20 Bicara Therapeutics shares in Q1 2026, an estimated $344.
  • Bicara Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4331 holding.
  • Carson Wealth (CWM LLC) first reported a position in Bicara Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Carson Wealth (CWM LLC)'s Bicara Therapeutics position peaked at $29K in Q1 2025.
  • 146 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.